Yang Di, Wei Kai, Gao Xuesong, Zhang Yijin, Gao Ping, Li Hongjie, Liu Xiaomin, Yuan Zheng, Xiao Te, Zhao Wenshan, Duan Xuefei
Beijing Ditan Hospital, Capital Medical University, 8th, Jingshundong Street, Chaoyang District, Beijing, 100015, PR China.
Future Virol. 2020 May;15(6):335-339. doi: 10.2217/fvl-2020-0030.
COVID-19 (coronavirus disease 2019) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and discovered in 2019. The clinical manifestations include fever, coughing, difficulty in breathing and even death from multiple organ failure. Nucleic acid test is the golden standard method for confirmation of infection. According to the Chinese 'Seventh Edition of the COVID-19 Diagnosis and Treatment Protocol', suspected patients with negative nucleic acid tests from two consecutive airway specimens can be excluded from diagnosis and released from quarantine. The current report describes a suspected COVID-19 case that had a history of close contact with a COVID-19 patient. The diagnosis was confirmed after the SARS-CoV-2 nucleic acid was detected after four sputum sample tests (sampling interval of at least 24 h).
新型冠状病毒肺炎(COVID-19,即2019年冠状病毒病)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染病,于2019年被发现。其临床表现包括发热、咳嗽、呼吸困难,甚至因多器官衰竭而死亡。核酸检测是确诊感染的金标准方法。根据中国《新型冠状病毒肺炎诊疗方案(第七版)》,连续两次呼吸道标本核酸检测阴性的疑似患者可排除诊断并解除隔离。本报告描述了1例有新型冠状病毒肺炎患者密切接触史的疑似病例。该患者在4次痰液样本检测(采样间隔至少24小时)后检测到SARS-CoV-2核酸,确诊为新型冠状病毒肺炎。